Having trouble accessing articles? Reset your cache.

Metadoxine: Completed Phase II enrollment

Alcobra completed enrollment of 36 patients with predominantly inattentive ADHD in a double-blind, crossover, Israeli

Read the full 152 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE